Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Northern Mariana Islands Health News.
May 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
June 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 |
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
Press releases published on June 17, 2025
BioAge Labs Expands Drug Discovery Platform with Data from Leading European Biobank
GlobeNewswire
·
June 17, 2025
Company to generate and analyze molecular profiles from over 17,000 samples from the HUNT Biobank in Norway to accelerate discovery of drug targets for aging-related diseases New data deepen platform insights into the biology of resilience across multiple …
Lark Health Names Industry Veteran Matthew Gibbs as President and Launches LarkVantage, an A.I. GLP-1 Cost Containment Platform
GlobeNewswire
·
June 17, 2025
MOUNTAIN VIEW, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Lark Health, a cardiometabolic and weight management platform that has supported nearly 2.5 million patients with 24/7 counseling, remote patient monitoring, and clinical escalations, today announced …
Capricor Therapeutics Announces Orphan Drug Designation for Becker Muscular Dystrophy and Regulatory Progress for Duchenne Muscular Dystrophy Program
GlobeNewswire
·
June 17, 2025
U.S. FDA grants Orphan Drug Designation to Deramiocel for the treatment of Becker Muscular Dystrophy, broadening Capricor’s focus in neuromuscular diseases Capricor remains on track for the August 31, 2025, PDUFA date for Deramiocel in Duchenne Muscular …
Ernst & Young LLP (EY US) Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award Winner
GlobeNewswire
·
June 17, 2025
POMPANO BEACH, Fla., June 17, 2025 (GLOBE NEWSWIRE) -- Ernst …
AIM ImmunoTech Resumes Trading on NYSE American
GlobeNewswire
·
June 17, 2025
OCALA, Fla., June 17, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that its common stock has resumed trading on the NYSE American under the symbol "AIM" and CUSIP 00901B303, effective at the …
Cannabix Technologies Receives Notice of Allowance from USPTO for Contactless Breath Analysis
GlobeNewswire
·
June 17, 2025
VANCOUVER, British Columbia, June 17, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) is pleased to report that the United States Patent and Trademark Office (USPTO) has issued a …
Lipella Pharmaceuticals Announces U.S. Patent Issuance for Diagnostic Technology
GlobeNewswire
·
June 17, 2025
PITTSBURGH, June 17, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing therapies for diseases with significant unmet need, today announced the …
Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China
GlobeNewswire
·
June 17, 2025
HINGHAM, Mass., June 17, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY Endovascular Robotic System, announced that it has been granted a critical patent in China by the China National Intellectual …
X-Chem Strengthens Executive Team with Strategic Finance and HR Appointments
GlobeNewswire
·
June 17, 2025
WALTHAM, Mass., June 17, 2025 (GLOBE NEWSWIRE) -- X-Chem, a global leader in data-driven drug discovery and DNA-encoded library (DEL) technology, today announced the appointments of Stephen Fair as Chief Financial Officer and Maureen Hart as Senior Vice …
FOXO TECHNOLOGIES INC.’S CRITICAL ACCESS HOSPITAL ANNOUNCES NEW WOUND CARE SERVICES OFFERING
GlobeNewswire
·
June 17, 2025
WEST PALM BEACH, FLORIDA, June 17, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that its critical access hospital, Big South Fork Medical Center located in Oneida, Tennessee, has commenced …
IMUNON Announces PlaCCine® DNA Vaccine Technology Abstract Selected for Oral Presentation at 10th International Conference on Vaccines Research & Development™
GlobeNewswire
·
June 17, 2025
Clinical Data Highlight PlaCCine’s Six-Month Durability, Temperature Stability, and Manufacturing Advantages Over mRNA Vaccines IMUNON Seeks Strategic Partner for PlaCCine® to Advance Novel Technology and Fund Core Pipeline with Non-Dilutive Capital …
CHO Plus Selected for 2025 BioTools Innovator Accelerator Program
GlobeNewswire
·
June 17, 2025
SOUTH SAN FRANCISCO, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Privately-held CHO Plus, Inc., a leading developer of biopharmaceutical manufacturing technology, announced its selection for the 2025 BioTools Innovator Accelerator, the first and only program …
Scienture Holdings Announces Cancelation of ELOC
GlobeNewswire
·
June 17, 2025
TAMPA, FL, June 17, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers …
Ashvattha Therapeutics to Present Data on Novel Nanomedicine Radiotracers at SNMMI Annual Meeting
GlobeNewswire
·
June 17, 2025
REDWOOD CITY, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue barriers to selectively target and reprogram activated cells in …
Marker Therapeutics and Cellipont Bioservices Announce Collaboration to Advance cGMP Manufacturing of MT-601, a Multi-Antigen Recognizing T Cell Therapy for Patients with Lymphoma
GlobeNewswire
·
June 17, 2025
HOUSTON, June 17, 2025 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid …
Press Release Biocartis NV: Biocartis Welcomes Ben Svarczkopf as Senior Vice President of Global Marketing
GlobeNewswire
·
June 17, 2025
PRESS RELEASE - 06/17/2025, 07:00 AM CDT Biocartis Welcomes Ben Svarczkopf as Senior Vice President of Global Marketing Itasca (IL), United States - June 17, 2025. Biocartis Group of Companies (“Biocartis”), an innovative precision oncology company, is …
ORYZON to Attend the 2025 Phelan-McDermid Syndrome (PMS) Congress in Barcelona on June 26-29
GlobeNewswire
·
June 17, 2025
Oryzon’s CSO, Dr. Jordi Xaus, will participate in a Panel entitled “Industry Perspectives Discussion” on June 27 70-90% of PMS patients show autistic related features, including aggression Agitation/Aggression in PMS and other ASD-related patient …
AI. Robotics. Automation. DLH Technology and Innovation Powers Recently Honored Projects
GlobeNewswire
·
June 17, 2025
ATLANTA, June 17, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital transformation and cybersecurity solutions …
Saudi Arabia Introduces Strategic Healthcare Vision and Global Partnerships at BIO 2025
GlobeNewswire
·
June 17, 2025
BOSTON, June 17, 2025 (GLOBE NEWSWIRE) -- Saudi Arabia officially opened its national pavilion today at the BIO International Convention 2025, marking a milestone moment in its journey to become a global biotechnology hub. The opening – Saudi Arabia’s …
Adial Pharmaceuticals Announces Pricing of $3.6 Million Public Offering
GlobeNewswire
·
June 17, 2025
GLEN ALLEN, Va., June 17, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related …